Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: BioElectronics Corporation

Market Cap 12.35M 10.77M 9.97M 9.34M 17.51M 1.17B 17.62M 118M 45.86M 574M 46.37M 45.37M 1.99B P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 25.69M 22.4M 20.75M 19.42M 36.43M 2.42B 36.65M 246M 95.39M 1.19B 96.45M 94.38M 4.14B EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 day-12.50%
1 week+33.33%
3 months+33.33%
1 week 0
Extreme 0.0003
0
1 month 0
Extreme 0.0003
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 14/11/2019
Sales & Marketing - 31/08/2017
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member - 14/11/2019
Chairman 85 14/06/2020
Director/Board Member - 02/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
-12.50%+33.33%+33.33%-33.33% 8.65M
-1.22%-2.32%+18.35%-13.53% 173B
+15.64%-1.48%-20.16%+23.51% 144B
-1.87%-2.00%-8.88%-26.73% 125B
+1.71%-3.99%-55.32%-16.62% 67.32B
-0.10%+1.87%+18.09%-4.98% 50.3B
-0.58%-1.16%-25.42%-34.65% 44.09B
+2.20%-1.92%+9.99%+4.90% 35.89B
-0.44%-1.20%+4.74%+32.04% 34.9B
+9.82%-4.53%-14.33%-21.69% 28.02B
Average -0.77%-0.24%-3.96%-9.11% 70.26B
Weighted average by Cap. +0.53%-2.00%-6.63%-6.42%

Financials

2020 2021
Net sales 830K 723K 670K 627K 1.18M 78.28M 1.18M 7.95M 3.08M 38.53M 3.11M 3.05M 134M 1.61M 1.4M 1.3M 1.22M 2.28M 152M 2.3M 15.42M 5.98M 74.75M 6.04M 5.91M 260M
Net income -1.16M -1.01M -936K -877K -1.64M -109M -1.65M -11.11M -4.31M -53.86M -4.35M -4.26M -187M -290K -253K -234K -219K -411K -27.35M -413K -2.78M -1.08M -13.46M -1.09M -1.06M -46.74M
Net Debt 13.07M 11.39M 10.55M 9.88M 18.53M 1.23B 18.64M 125M 48.52M 607M 49.05M 48M 2.11B 13.34M 11.63M 10.77M 10.09M 18.91M 1.26B 19.03M 128M 49.53M 620M 50.08M 49.01M 2.15B
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
18/06/26 0.000350 $ -12.50% 2,740,313
17/06/26 0.000400 $ +33.33% 10,493,800
16/06/26 0.000300 $ -15.49% 29,688,490
15/06/26 0.000355 $ +1.43% 18,681,334
12/06/26 0.000350 $ +16.67% 4,679,322
  1. Stock Market
  2. Stocks
  3. BIEL Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!